<ѻýҕl>Mortality in U.S. Youth; Gene Therapy for Sickle Cell Diseaseѻýҕl> Also in TTHealthWatch: updated breast cancer screening guidelines May 11, 2024 podcast
<ѻýҕl>Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exerciseѻýҕl> News, features, and commentary about cancer-related issues May 10, 2024
<ѻýҕl>Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Showѻýҕl> Study finds survival is comparable to that seen in younger patients in VIALE-A trial May 09, 2024
<ѻýҕl>Impact of Recombinant Replacement Therapy Detailed in Genetic Clotting Disorderѻýҕl> Trial that led to FDA approval shows a big difference in replacement levels versus usual care May 01, 2024
<ѻýҕl>Genetics and Genetic Testing to Inform Myelofibrosis Clinical Managementѻýҕl> Genetics already informs prognosis, may help guide therapy development beyond JAK2 inhibition May 01, 2024
<ѻýҕl>Myelofibrosis: A Rare Malignancy Attracting More and More Attentionѻýҕl> Increased interest follows mutation discoveries, development of targeted therapies May 01, 2024
<ѻýҕl>New E. Coli Outbreak; How ECMO Redefines Death; A Step Closer to Universal Bloodѻýҕl> Health news and commentary gathered by ѻýҕl staff May 01, 2024
<ѻýҕl>FDA Approves First Drug for WHIM Syndromeѻýҕl> CXCR4 antagonist mavorixafor effectively boosts neutrophils and lymphocytes to reduce infections Apr 29, 2024
<ѻýҕl>Clue to Aspirin, Colon Cancer Link; New Lutathera Approval; AI & Electronic Recordsѻýҕl> News, features, and commentary about cancer-related issues Apr 26, 2024
<ѻýҕl>FDA OKs Second Gene Therapy for Hemophilia Bѻýҕl> One dose of fidanacogene elaparvovec proved noninferior to standard prophylactic factor IX Apr 26, 2024
<ѻýҕl>Quadruplet Shows 'Excellent Activity' in Myeloma Patients Who Defer HSCTѻýҕl> ORR reaches 90% with isatuximab plus KRd in newly diagnosed disease Apr 26, 2024
<ѻýҕl>High Deep-Remission Rate With Triple Regimen for Relapsed/Refractory CLLѻýҕl> Undetectable disease rate over 90%, ctDNA also promising for earlier detection of recurrence Apr 24, 2024
<ѻýҕl>CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancersѻýҕl> "All-in-one" approach appears safe, effective, in patients with relapsed/refractory disease Apr 24, 2024
<ѻýҕl>Immunotherapy During Pregnancy Just as Safe as Other Cancer Drugsѻýҕl> However, use should be avoided "if possible" due to risk of rare immune-related adverse events Apr 17, 2024
<ѻýҕl>FDA Approves Earlier Use of CAR-T Products for Myelomaѻýҕl> Carvykti and Abecma move to second- and third-line, respectively Apr 08, 2024
<ѻýҕl>High Response Rate in R/R Multiple Myeloma With Bispecific Antibodyѻýҕl> ORR of 71% that deepened over time and favorable safety profile with linvoseltamab Apr 08, 2024
<ѻýҕl>Factor D Inhibitor Wins Approval for PNH With Extravascular Hemolysisѻýҕl> Danicopan significantly improved hemoglobin at 12 weeks when added to a C5 inhibitor Apr 04, 2024
<ѻýҕl>FDA OKs Injectable Antibiotic for Three Different Usesѻýҕl> Ceftobiprole was at least comparable to currently used medications in studies Apr 03, 2024
<ѻýҕl>Chemo and Heart Disease; Flawed Lung Cancer Screening; New Vax Recommendationsѻýҕl> News, features, and commentary about cancer-related issues Mar 29, 2024
<ѻýҕl>PD-1 Inhibitor Plus Chemotherapy Shows Promising Activity in Rare Lymphomaѻýҕl> The combination induced responses in all 34 patients with advanced extranodal NK/T-cell lymphoma Mar 28, 2024
<ѻýҕl>Breastfeeding Tied to Reduced Childhood Leukemia Riskѻýҕl> Lower pediatric ALL risk in Danish study when mothers exclusively breastfed for 3 months or more Mar 27, 2024
<ѻýҕl>New Monoclonal Authorized to Prevent COVID in Immunocompromised Peopleѻýҕl> No such option has been available since FDA revoked the authorization of Evusheld last year Mar 22, 2024
<ѻýҕl>FDA Approves New Frontline Regimen for Aggressive ALLѻýҕl> Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases Mar 22, 2024
<ѻýҕl>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancerѻýҕl> News, features, and commentary about cancer-related issues Mar 22, 2024
<ѻýҕl>Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicinѻýҕl> Dose-dependent increase regardless of age at treatment or chest radiotherapy Mar 19, 2024
<ѻýҕl>FDA Panel Gives Thumbs Up to Earlier Use of CAR T-Cell Therapy in Multiple Myelomaѻýҕl> Cilta-cel, ide-cel win support despite concerns about early mortality risk Mar 16, 2024
<ѻýҕl>FDA Approves First CAR-T for Chronic Lymphocytic Leukemiaѻýҕl> Lisocabtagene maraleucel (Breyanzi) nabs new indication for relapsed or refractory CLL/SLL Mar 15, 2024
<ѻýҕl>FDA Panel Endorses Imetelstat for MDS-Related Anemiaѻýҕl> By 12-2 vote, members find improvement in transfusion independence outweighs risk Mar 14, 2024
<ѻýҕl>Early Death Risk Muddies Risk-Benefit Assessment of CAR-T Therapies for Myelomaѻýҕl> FDA advisory panel to weigh the evidence for cilta-cel, ide-cel in day-long meeting Mar 14, 2024
<ѻýҕl>Getting Prostate Cancer Drugs Sooner; Limiting Toxic Emissions; FTC Sues 'Charity'ѻýҕl> News, features, and commentary about cancer-related issues Mar 14, 2024
<ѻýҕl>FDA Staff Cast Doubt on Novel Drug for MDS-Related Anemiaѻýҕl> Agency asking its advisors if benefits outweigh risks for patients who fail on standard treatment Mar 12, 2024
<ѻýҕl>Sickle Cell Pain Hospitalizations Rose After CDC's Opioid Recsѻýҕl> Agency's 2016 guidance may have contributed to reduced access to opioids, and more pain Mar 11, 2024
<ѻýҕl>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertuѻýҕl> News, features, and commentary about cancer-related issues Mar 07, 2024
<ѻýҕl>Novel Regimens Yield High Response Rates for Older, Hodgkin Lymphoma Patientsѻýҕl> Talk of potential cure for some patients with brentuximab plus dacarbazine or nivolumab Mar 06, 2024
<ѻýҕl>IVF Helps Patients Trying to Build Families. An Alabama Court Put That in Doubtѻýҕl> "Every month that you're not pregnant feels like grief" Mar 05, 2024
<ѻýҕl>All-Oral AML Regimen Shows Promise for Older, Unfit Patientsѻýҕl> Response rate of 64% in newly diagnosed patients, 46% in those with refractory/relapsed disease Mar 05, 2024
<ѻýҕl>New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Resultsѻýҕl> News, features, and commentary about cancer-related issues Mar 01, 2024
<ѻýҕl>PROs for Cutaneous Chronic GVHD After Transplant Tied to Disease Severity, Mortalityѻýҕl> Baseline QOL, symptom burden could inform risk stratification, treatment decisions Feb 28, 2024
<ѻýҕl>Amy Schumer's Diagnosis; FDA Yanks Cancer Drug; Nursing Student Murderedѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Feb 26, 2024
<ѻýҕl>Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warningѻýҕl> News, features, and commentary about cancer-related issues Feb 23, 2024